Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-12

FDA Approved: PALIPERIDONE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' generic paliperidone through an original application (ANDA). The approval covers use for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PALIPERIDONE (paliperidone)

Snippet

ORIG AP for PALIPERIDONE (PALIPERIDONE)